Skip to main content

Table 2 Histopathological classification*, age and development of end-stage renal disease in hAPLN patients

From: Histological antiphospholipid-associated nephropathy versus lupus nephritis in patients with systemic lupus erythematosus: an observational cross-sectional study with longitudinal follow-up

Patient number Biopsies prior to study start (age) Biopsy prior to hAPLN (age) Biopsy I (age) Biopsy II (age) Biopsy III (age) ESRD (age)
1 - - hAPLN (54) - - -
2 II (36) - hAPLN/IV (38) II (39) V (41) + (55)
3 - - hAPLN (49) hAPLN (53) - -
4 hAPLN (8) - hAPLN/II (28) - - + (28)
5 - IV (35) hAPLN (47) - - -
II (36)
IV (39)
IV(42)
6 IV (26) V (35) hAPLN/V (36) - - -
  IV (28)
  III (29)
7 - II (40) hAPLN/V (43) - - -
8 - II (27) hAPLN (29) Scarring (29) hAPLN (34) + (38)
9 - III (25) hAPLN/II (26) - - -
10 V (16) V (22) hAPLN/V (27) V (33) - -
V (23)
V (24)
V (26)
11 II + V (24) - hAPLN/II + V (52) - - -
12 - - hAPLN/V (30) hAPLN/V (33) - + (36)
13 - - hAPLN/V (58) V (59) - -
14 - - hAPLN (61) - - -
15 - - hAPLN (55) hAPLN (58) - + (58)
16 V (56) - hAPLN (62) - - + (66)
  1. *Class II, III, IV and V refers to either the World Health Organization [16] or International Society of Nephrology/Renal Pathology Society [17] classification criteria of lupus nephritis, histopathological antiphospholipid-associated nephropathy (hAPLN) and end-stage renal disease (ESRD).